Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

In a written answer to Parliament, Kenneth Clarke announced a revised leaflet "AIDS and how it concerns blood donors" was to be given individually to each donor or potential donor.

Published on: 24 September, 2024

DHSSNI accepted the recommendations of the second report of the Maycock Group, subject to a few reservations.

Published on: 24 September, 2024

Mary Sibellas wrote to Dr Geffen about the formation of an Advisory Group on Viral Hepatitis and suggested it should be a free-standing committee which would only meet occasionally but would be available to give advice if required.

Published on: 24 September, 2024

Dr Geffen submitted a paper to Dr Evans proposing the establishment of an advisory group on hepatitis.

Published on: 24 September, 2024

A meeting took place to discuss the setting up and terms of reference of an advisory group on viral hepatitis.

Published on: 24 September, 2024

Dr Geffen wrote to Dr Evans about the formation of an Advisory Group on Hepatitis.

Published on: 24 September, 2024

The terms of reference of the Advisory Group on Hepatitis were "To provide medical advice to the Chief Medical Officers of the Health Departments of the United Kingdom on all aspects of communicable hepatitis."

Published on: 24 September, 2024

The second meeting of the Advisory Group on Hepatitis took place.

Published on: 24 September, 2024

Dr John Holgate wrote to Stanley Godfrey about the safety of American Factor 8.

Published on: 24 September, 2024

The Observer published an article which suggested Factor 8 concentrates "may pose a grave threat to the health of haemophiliacs who inject it."

Published on: 24 September, 2024

A memo from the DHSS recorded Dr Walford had confirmed that the value to people with severe haemophilia of Factor 8 and 9 concentrates "far outweigh the possible, and as yet unproven hazards of the transmission of acquired immune deficiency syndrome."

Published on: 24 September, 2024

The Communicable Disease Report reported a "probable" case of AIDS in Cardiff.

Published on: 24 September, 2024

Dr Galbraith telephoned Dr Sibellas and reported that the Cardiff patient had the right symptoms and signs for a diagnosis of AIDS.

Published on: 24 September, 2024

Dr Sibellas sent Dr Field a minute setting out her understanding that Dr Galbraith had written to him suggesting that there should be a Working Party on AIDS. The idea was abandoned.

Published on: 24 September, 2024

Dr Walford wrote a memo to Dr Field following the reference centre directors' special meeting. In her view the temporary withdrawal of American blood products was "premature" as it did not consider "the risks to haemophiliacs of withdrawing a major source of their FVIII supplies".

Published on: 24 September, 2024

Dr Walford sent a memo to Dr Field that stated she "certainly would not wish to press for a formal Working Party at this stage".

Published on: 24 September, 2024

A background paper was prepared for an internal DHSS meeting to consider AIDS. It included the "no conclusive proof" line. The paper also referred to "one suspect case in Cardiff" but Professor Bloom did not not "consider that it should be regarded as a confirmed case."

Published on: 24 September, 2024

A background paper was prepared for an internal DHSS meeting to consider AIDS. It referred to "one suspect case in Cardiff". Professor Bloom did not not "consider that it should be regarded as a confirmed case." The reference centre directors agreed that no restriction should be placed on the use of imported Factor 8 concentrate "other than to continue with the present policy of using only NHS material for children under the age of 4 years and for mild haemophiliacs".

Published on: 24 September, 2024

A paper on the "Implications of AIDS for production of FVIII at BPL" suggested there would be major operational and financial problems for RTCs if there were to be a significantly increased demand for cryoprecipitate.

Published on: 24 September, 2024

An internal DHSS meeting was held to discuss the implications of recent media reports on AIDS and to consider possible courses of action. It was agreed to seek the CBLA's comment on greater use of single donor or small pool products and the introduction on heat-treated concentrate; and that a recommendation would be made for an early meeting between ministers and the Haemophilia Society.

Published on: 24 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2377
  • Page 2378
  • Page 2379
  • Page 2380
  • Current page 2381
  • Page 2382
  • Page 2383
  • Page 2384
  • Page 2385
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.